Literature DB >> 16135861

Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription.

Hiroto Ito1, Asuka Koyama, Teruhiko Higuchi.   

Abstract

BACKGROUND: Despite extensive research and recommendations regarding the optimal prescription of antipsychotic drugs, polypharmacy and excessive dosing still prevail. AIMS: To identify the factors associated with the polypharmacy and excessive dosing phenomena.
METHOD: We studied 139 patients with schizophrenia, in 19 acute psychiatric units in Japanese hospitals, who were due to be discharged between October and December 2003. We examined patient characteristics, nurses' requests, and psychiatrists' characteristics and perceptions of prescribing practice and algorithms.
RESULTS: Polypharmacy and excessive dosing were observed in 96 cases. Logistic regression analysis revealed that the use of multiple medications and excessive dosing were influenced by the psychiatrist's scepticism towards the use of algorithms, nurses' requests for more drugs and the patient's clinical condition.
CONCLUSIONS: Educational interventions are necessary for psychiatrists and nurses to follow evidence-based guidelines or algorithms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135861     DOI: 10.1192/bjp.187.3.243

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  32 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

Authors:  Juan A Gallego; John Bonetti; Jianping Zhang; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2012-04-24       Impact factor: 4.939

3.  Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid program.

Authors:  Robert J Constantine; Ross Andel; Rajiv Tandon
Journal:  Community Ment Health J       Date:  2010-01-23

4.  Attitudes toward taking medication among outpatients with schizophrenia: cross-national comparison between Tokyo and Beijing.

Authors:  Naoaki Kuroda; Shiyou Sun; Chih-Kuang Lin; Nobuaki Morita; Hirotaka Kashiwase; Fude Yang; Yoji Nakatani
Journal:  Environ Health Prev Med       Date:  2008-08-12       Impact factor: 3.674

Review 5.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

6.  Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.

Authors:  Lone Baandrup; Jan Sørensen; Henrik Lublin; Merete Nordentoft; Birte Glenthoj
Journal:  Eur J Health Econ       Date:  2011-03-31

7.  Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme.

Authors:  Shubhra Mace; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2015-02

8.  Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior.

Authors:  Christoph U Correll; Ladan Shaikh; Juan A Gallego; Jeffrey Nachbar; Vladimir Olshanskiy; Taishiro Kishimoto; John M Kane
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

9.  Patterns of care in patients discharged from acute psychiatric inpatient facilities: a national survey in Italy.

Authors:  Antonio Preti; Paola Rucci; Antonella Gigantesco; Giovanni Santone; Angelo Picardi; Rossella Miglio; Giovanni de Girolamo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-02-11       Impact factor: 4.328

10.  Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.

Authors:  Taishiro Kishimoto; Koichiro Watanabe; Hiroyuki Uchida; Masaru Mimura; John M Kane; Christoph U Correll
Journal:  Psychiatry Res       Date:  2013-04-18       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.